The -429 T/C and -374 T/A Gene Polymorphisms of the Receptor of Advanced Glycation End Products Gene are not Risk Factors for Diabetic Retinopathy in Caucasians with Type 2 Diabetes

Klinische Monatsblatter fur Augenheilkunde

Volumn 220, Issue 12, 2003, Pages 873-876

  Petrovič, Mojca Globočnik ^a   Steblovnik, Klemen ^a   Peterlin, Borut ^a   Petrovič, Daniel ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

374 T A gene polymorphism; 429 T C gene polymorphism; Caucasians; Diabetic retinopathy; Genetic risk factors; Proliferative diabetic retinopathy; Receptor of advanced glycation end products gene; Type 2 diabetes

Indexed keywords

ADENINE; ADVANCED GLYCATION END PRODUCT RECEPTOR; CYTOSINE; THYMINE;

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FEMALE; GENE ISOLATION; GENE LOCATION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROLIFERATIVE RETINOPATHY; RAGE GENE; RECEPTOR GENE; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MATHEMATICAL COMPUTING; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; REFERENCE VALUES; SOFTWARE; VITREORETINOPATHY, PROLIFERATIVE;

EID: 0347089070     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-812553     Document Type: Article

References (15)

1. Brownlee M. Advanced protein glycosylation in diabetes in aging. Annu Rev Med 1995; 46: 223-234
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820
3. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification ETDRS report number 10. Ophthalmology 1991; 98, Suppl 5: 786-806
4. Hudson BI, Stickland MH, Futers TS, Grant PJ. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001; 50: 1505-1511
5. Keen H, Lee ET, Russell D, Miki E, Bennett PH, Lu M. The appearance of retinopathy and progression to proliferative retinopathy: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44, Suppl 2: 22-30
6. Klein R, Klein BEK. Visual disorders. In: Harris Cl, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH (eds): Diabetes in America. Bethesda: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 1995: 293-338
7. Kumaramanickavel G, Ramprasad VL, Sripriya S, Upadyay NK, Paul PG, Sharma T. Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. J Diabetes Complications 2002; 16: 391-394
8. Okamoto T, Yamagishi S, Inagaki Y et al. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin. FASEB J 2002; 16: 1928-1930
9. Porta M, Sjoelie AK, Chaturvedi N et al. for EURODIAB Prospective Complications Study Group. Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia 2001; 44: 2203-2209
10. Ritthaler U, Deng Y, Zhang Yet al. Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol 1995; 146: 688-694
11. Schmidt AM, Stern DM. RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes. Trends Endocrinol Metab 2000; 11: 368-375
12. Soulis T, Thallas V, Youssef S et al. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 1997; 40: 619-628
13. Stitt AW, He C, Vlassara H. Characterisation of advanced glycation end-product receptor complex in human vascular endothelial cells. Viochem Biophys Res Commun 1999; 256: 549-556
14. Winocour PD. Platelet abnormalities in diabetes mellitus. Diabetes 1992; 41, Suppl 2: 26-31
15. World Health Organization diabetes mellitus: report of a WHO study group. WHO Tech Rep Ser No 727, 1985: 9-10